Drugs / Camptothecin-20-O-Propionate Hydrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00947739 | Sep 2008 → Dec 2012 | cancer, lymphoma | New Mexico Cancer Research Alliance | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Camptothecin-20-O-Propionate Hydrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00947739 ↗ |
| Route | Oral | “Camptothecin-20-O-Propionate hydrate (CZ48) administered orally every day” NCT00947739 ↗ |